Systemic sclerosis (scleroderma)

Adil I. Khan, Joseph Susa, M. Qasim Ansari

Research output: Contribution to journalReview article

Abstract

In summary, systemic sclerosis is a chronic inflammatory disease that can affect both the subcutaneous tissue and viscera. Clinical symptoms due to tissue fibrosis, vascular damage, and the generation of antinuclear antibodies. Laboratory diagnosis requires the detection ANA and anti- Scl-70 antibodies. While the etiology remains unknown, better understanding of the disease, have improved the treatment and overall disease prognosis.

Original languageEnglish (US)
Pages (from-to)723-726
Number of pages4
JournalLaboratory Medicine
Volume36
Issue number11
DOIs
StatePublished - Nov 2005

ASJC Scopus subject areas

  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint Dive into the research topics of 'Systemic sclerosis (scleroderma)'. Together they form a unique fingerprint.

  • Cite this

    Khan, A. I., Susa, J., & Ansari, M. Q. (2005). Systemic sclerosis (scleroderma). Laboratory Medicine, 36(11), 723-726. https://doi.org/10.1309/DQXMW624C3RM84E2